ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
Tomographic phenotypes and conditional time to atrophic conversion in dry age-related macular degeneration among progressors: an interval-censored study.
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIdentifying progression trajectories of intermediate age-related macular degeneration (iAMD) is crucial to determine candidates for future therapies. This study assessed whether the OCT phenotype could predict the progression to complete retinal pigment epithelium and outer retinal atrophy (cRORA).
methodsThis retrospective study included eyes with dry AMD progressing to cRORA. Baseline OCT phenotypes were assigned with a stepwise clinical rationale: incomplete RORA (iRORA) > acquired vitelliform lesions (AVL) > drusenoid pigment epithelial detachment (dPED) > subretinal drusenoid deposits (SDD) > soft drusen, with soft drusen as the reference group. Time to cRORA was estimated with accelerated failure time models.
resultsAmong the 129 eyes of 89 patients progressing to cRORA, the median time to cRORA for the overall cohort was 4.83 years. Eyes with iRORA showed the shortest median time to cRORA (0.75 years), followed by dPED (2.53 years) and AVL (4.07 years). SDD and soft drusen demonstrated the slowest progression (6.76 and 6.48 years, respectively). In adjusted AFT models baseline hyperreflective foci (HRF), iRORA (TR, 0.21; 95% CI, 0.13-0.33; p < 0.001) and dPED (TR, 0.59; 95% CI, 0.40-0.86; p = 0.007) independently predicted shorter time to cRORA. Presence of HRF was independently associated with faster progression (TR, 0.57; 95% CI, 0.44-0.74; p < 0.001).
conclusionIn eyes with dry AMD progressing to cRORA, baseline OCT phenotypes were associated with different temporal trajectories to cRORA. These findings will help prognostic stratification and the selection of candidates for emerging therapeutic interventions.
Indexed as
Identifiers
42377419What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.